Hepatic artery embolization is an interventional minimally invasive procedure that is now very widely used in clinical practice. It can be used for the treatment of ruptured hepatocellular carcinoma bleeding, as well as for the treatment of primary hepatocellular carcinoma or hepatic hemangioma. Hepatic artery embolization is performed under local anesthesia. A percutaneous femoral artery puncture catheter is delivered to the hepatic artery, the location of the diseased vessel is clarified by imaging, and a super-selective cannula is inserted into the diseased hepatic artery branches to select different types of embolic agents for injection, so as to achieve the purpose of clinical treatment. However, in the treatment of hepatocellular carcinoma, hepatic artery embolization is often applied simultaneously with the injection of chemotherapeutic drugs via hepatic artery, which not only can make the tumor ischemic and necrotic, but also can further kill the residual cancer cells through chemotherapeutic drugs. Hepatic artery embolization chemotherapy can be used either as a stand-alone treatment or as an adjunctive treatment before or after surgery. Pre-surgical embolization can shrink the lesion and thus gain the chance of radical surgical resection, while post-surgical arterial embolization chemotherapy can reduce the recurrence as well as metastasis of hepatocellular carcinoma.